Literature DB >> 33168607

Might Confounding Factors Have an Effect on Suboptimal Dosing of Fluconazole in Critically Ill Patients?

Emre Kara1, Aygin Bayraktar Ekincioglu2, Gokhan Metan3.   

Abstract

Entities:  

Keywords:  critical illness; fluconazole; pharmacokinetics

Mesh：

Substances：

Year:  2021        PMID： 33168607      PMCID： PMC7848992          DOI： 10.1128/AAC.02118-20

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  9 in total

1.  Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions.

Authors:  D Tony Yu; Josh F Peterson; Diane L Seger; William C Gerth; David W Bates
Journal:  Pharmacoepidemiol Drug Saf       Date:  2005-11       Impact factor: 2.890

2.  Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill Patients.

Authors:  Abdulaziz S Alobaid; Steven C Wallis; Paul Jarrett; Therese Starr; Janine Stuart; Melissa Lassig-Smith; Jenny Lisette Ordóñez Mejia; Michael S Roberts; Mahipal G Sinnollareddy; Claire Roger; Jeffrey Lipman; Jason A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

3.  Suboptimal Dosing of Fluconazole in Critically Ill Patients: Time To Rethink Dosing.

Authors:  Eline W Muilwijk; Dylan W de Lange; Jeroen A Schouten; Roeland E Wasmann; Rob Ter Heine; David M Burger; Angela Colbers; Pieter J Haas; Paul E Verweij; Peter Pickkers; Roger J Brüggemann
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

4.  Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome.

Authors:  Annette C Reboli; Andrew F Shorr; Coleman Rotstein; Peter G Pappas; Daniel H Kett; Haran T Schlamm; Arlene L Reisman; Pinaki Biswas; Thomas J Walsh
Journal:  BMC Infect Dis       Date:  2011-09-30       Impact factor: 3.090

5.  Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study.

Authors:  Mahipal G Sinnollareddy; Jason A Roberts; Jeffrey Lipman; Murat Akova; Matteo Bassetti; Jan J De Waele; Kirsi-Maija Kaukonen; Despoina Koulenti; Claude Martin; Philippe Montravers; Jordi Rello; Andrew Rhodes; Therese Starr; Steven C Wallis; George Dimopoulos
Journal:  Crit Care       Date:  2015-02-04       Impact factor: 9.097

6.  The Effect on mortality of fluconazole or echinocandins treatment in candidemia in internal medicine wards [corrected].

Authors:  Francesco G De Rosa; Silvia Corcione; Claudia Filippini; Stefania Raviolo; Lucina Fossati; Chiara Montrucchio; Chiara Aldieri; Alessia Petrolo; Rossana Cavallo; Giovanni Di Perri
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

Review 7.  Estimation of renal function in the intensive care unit: the covert concepts brought to light.

Authors:  Sham Sunder; Rajesh Jayaraman; Himanshu Sekhar Mahapatra; Satyanand Sathi; Venkata Ramanan; Prabhu Kanchi; Anurag Gupta; Sunil Kumar Daksh; Pranit Ram
Journal:  J Intensive Care       Date:  2014-05-07

8.  The epidemiology of polypharmacy in older adults: register-based prospective cohort study.

Authors:  Lucas Morin; Kristina Johnell; Marie-Laure Laroche; Johan Fastbom; Jonas W Wastesson
Journal:  Clin Epidemiol       Date:  2018-03-12       Impact factor: 4.790

9.  A study of harmful drug-drug interactions due to polypharmacy in hospitalized patients in Goa Medical College.

Authors:  Akshay Khandeparkar; Padmanabh V Rataboli
Journal:  Perspect Clin Res       Date:  2017 Oct-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.